Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|June 1, 1977
A comparison of the antiserotonin, antihistamine, and anticholinergic activity of cyproheptadine with analogues having furan nuclei fused to the 10,11-vinylene bridgeD C Remy, A W Raab, K E Rittle, et al.Journal of Medicinal Chemistry|December 1, 1977
(+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadineD C Remy, K E Rittle, C A Hunt, et al.Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy terminiM G Bock, R M DiPardo, B E Evans, et al.Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.Journal of Medicinal Chemistry|December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonistsB E Evans, G F Lundell, K F Gilbert, et al.Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.Journal of Medicinal Chemistry|December 24, 1993
Development of 1,4-benzodiazepine cholecystokinin type B antagonistsM G Bock, R M DiPardo, B E Evans, et al.Pageof 2